Search research articles
Contact Us
Filters
Showing results (111-120 of 862) with videos related to
Page
of 87
Sort By:
European Archives of Psychiatry and Clinical Neuroscience
|
August 21, 2023
New treatment strategies for mental health
Kenji Hashimoto, Andrea Schmitt
Asian Journal of Psychiatry
|
October 4, 2024
Therapeutic potential of ketamine in management of epilepsy: Clinical implications and mechanistic insights
Yunfei Tan, Kenji Hashimoto
Annals of General Psychiatry
|
June 25, 2010
Sigma-1 receptor agonist fluvoxamine for postoperative delirium in older adults: report of three cases
Tsutomu Furuse, Kenji Hashimoto
Biological Psychiatry
|
February 8, 2018
What Are the Causes for Discrepancies of Antidepressant Actions of (2R,6R)-Hydroxynorketamine?
Kenji Hashimoto, Yukihiko Shirayama
Journal of Affective Disorders
|
April 28, 2020
Risk of psychosis after repeated intermittent administration of (S)-ketamine, but not (R)-ketamine, in mice
Yunfei Tan, Kenji Hashimoto
Neuron
|
July 21, 2022
The role of hippocampal KCNQ2 channel in antidepressant actions of ketamine
Li Ma, Kenji Hashimoto
Annals of General Psychiatry
|
April 27, 2010
Sigma-1 receptor agonist fluvoxamine for delirium in intensive care units: report of five cases
Tsutomu Furuse, Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience
|
July 16, 2018
Is (S)-norketamine an alternative antidepressant for esketamine?
Kenji Hashimoto, Chun Yang
Expert Review of Neurotherapeutics
|
December 5, 2018
An update on ketamine and its two enantiomers as rapid-acting antidepressants
Kai Zhang, Kenji Hashimoto
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
November 25, 2015
Early Intervention for Psychosis with N-Methyl-D-Aspartate Receptor Modulators
Chao Dong, Kenji Hashimoto
Page
of 87
Search research articles
Search
Showing results (111-120 of 862) with videos related to
Sort By:
Page
of 87
European Archives of Psychiatry and Clinical Neuroscience
|
August 21, 2023
New treatment strategies for mental health
Kenji Hashimoto, Andrea Schmitt
Asian Journal of Psychiatry
|
October 4, 2024
Therapeutic potential of ketamine in management of epilepsy: Clinical implications and mechanistic insights
Yunfei Tan, Kenji Hashimoto
Annals of General Psychiatry
|
June 25, 2010
Sigma-1 receptor agonist fluvoxamine for postoperative delirium in older adults: report of three cases
Tsutomu Furuse, Kenji Hashimoto
Biological Psychiatry
|
February 8, 2018
What Are the Causes for Discrepancies of Antidepressant Actions of (2R,6R)-Hydroxynorketamine?
Kenji Hashimoto, Yukihiko Shirayama
Journal of Affective Disorders
|
April 28, 2020
Risk of psychosis after repeated intermittent administration of (S)-ketamine, but not (R)-ketamine, in mice
Yunfei Tan, Kenji Hashimoto
Neuron
|
July 21, 2022
The role of hippocampal KCNQ2 channel in antidepressant actions of ketamine
Li Ma, Kenji Hashimoto
Annals of General Psychiatry
|
April 27, 2010
Sigma-1 receptor agonist fluvoxamine for delirium in intensive care units: report of five cases
Tsutomu Furuse, Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience
|
July 16, 2018
Is (S)-norketamine an alternative antidepressant for esketamine?
Kenji Hashimoto, Chun Yang
Expert Review of Neurotherapeutics
|
December 5, 2018
An update on ketamine and its two enantiomers as rapid-acting antidepressants
Kai Zhang, Kenji Hashimoto
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
November 25, 2015
Early Intervention for Psychosis with N-Methyl-D-Aspartate Receptor Modulators
Chao Dong, Kenji Hashimoto
Page
of 87